Clinical Trials match your criteria
-
Study of Optune® (TTFields, 200khz) Concomitant with Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma
EF-32 (TRIDENT): A Pivotal Randomized, Open-Label Study of Optune® (TTFields, 200khz) Concomitant with Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma
-
GBM Radiation Therapy + Temozolomide + Pembro + Tumor Vaccine
17C0034: A Randomized Double Blind Phase II trial of Surgery, Radiation Therapy plus Temozolomide and Pembrolizumab with and without HSPPC-96 in patients with newly diagnosed Glioblastoma (GBM)
-
Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer
EF-25: Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC)
-
Vaccine Therapy for Newly Diagnosed Glioblastoma GBM
ATTAC-II: A Phase II Randomized, Blinded, and Placebo-controlled Trial of CMV RNA-Pulsed Dendritic Cells with Tetanus-Diphtheria Toxoid Vaccine in Patients with Newly-Diagnosed Glioblastoma
-
Brain Tumor Tissue Collection
Florida Center for Brain Tumor Research
